MHRA Registration Risks and Protecting UK Market Access(Banner)
Medical
Profile picture of Deepa

Deepa

Deepa is a Regulatory Affairs and Quality professional with 10 years of experience supporting medical device manufacturers across Europe, the United States, and Asia. She specialises in regulatory strategy, ISO 13485 compliance, and enabling sustainable global market access for Class I–III devices and Software as a Medical Device (SaMD).

Medical Device MHRA Registration: Penalties, Product Withdrawal and How to Protect Your UK Market Access

You’ve built a great product. You’ve done your CE marking for the EU. Maybe you’ve already started shipping to UK distributors. The UK is one of the largest medical device markets in Europe, and the opportunity is hard to ignore.

But there’s a question that should be front of mind for every manufacturer selling into Great Britain: Are you actually registered with the MHRA?

Not CE marked. Not EU MDR compliant. Specifically registered with the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s post-Brexit regulatory body that now operates entirely independently of the EU system.

If the answer isn’t clear, read on. The consequences of getting this wrong are serious, they are escalating, and they catch manufacturers off guard more often than you might think.

The UK Is Not the EU Anymore

This is the single biggest misconception we see from manufacturers entering the UK market. The UK left the EU’s regulatory framework on 1 January 2021. CE marking alone is not enough to sell in Great Britain, which covers England, Scotland, and Wales: CE marks are recognised there only for a limited period, and you must still register with the MHRA and appoint a UK Responsible Person.

Since then, the MHRA has built out its own device registration regime. The UK Conformity Assessed (UKCA) mark is the UK’s equivalent of CE marking, and MHRA registration is a mandatory requirement for placing medical devices on the GB market.

Northern Ireland operates under different rules. It continues to follow EU MDR/IVDR under the Windsor Framework. If you are selling into England, Scotland, or Wales, however, MHRA registration applies to you.

The MHRA has granted transitional arrangements since Brexit, allowing CE-marked devices to continue being sold in GB under specific conditions. Those transitional periods have been extended on several occasions, but they are not permanent. The current position for your specific device category should be verified directly on the MHRA website before you rely on any transitional provision.

What Does MHRA Medical Registration Actually Require?

What Does MHRA Medical Registration Actually Require

Before getting to the consequences of non-compliance, it helps to be clear on what MHRA registration actually involves, because it goes beyond filling in a form online.

To register a medical device with the MHRA, manufacturers typically need to:

  • Have a registered UK Responsible Person (RP), a UK-based individual or company legally accountable for the device’s compliance
  • Submit device registration through the MHRA’s online portal
  • Hold valid conformity assessment documentation (such as a CE certificate or UKCA certificate)
  • Ensure labelling meets UK-specific requirements, including UK address details
  • Meet post-market surveillance and vigilance reporting obligations under UK regulations

If you are a non-UK manufacturer, whether based in the EU, US, Asia, or elsewhere, you cannot register directly with the MHRA. You must appoint a UK Responsible Person to act on your behalf. This is a legal requirement with no workaround.

The Consequences of Selling Without MHRA Registration

This is where the stakes get serious. The MHRA holds broad enforcement powers under the Medical Devices Regulations 2002 (as amended), and since Brexit it has been investing in its enforcement capability.

1. Enforcement Notices and Recall

The MHRA can issue compliance, suspension, safety and information notices, and can organise a recall where nothing else would protect health and safety. If your devices are suspended or recalled, your products are pulled from distribution, removed from shelves, and your UK customers are left without supply at short notice.

The commercial fallout from a sudden withdrawal is significant: lost revenue, damaged customer relationships, and potential liability for supply disruptions in clinical settings. If your device is used in hospitals or care homes, your customers will face urgent procurement problems, and they will look to you for answers.

2. Criminal Prosecution and Personal Liability

Non-compliance with the Medical Devices Regulations is a criminal offence in the UK. The MHRA can refer cases for prosecution, with penalties that include:

  • Fines for the company
  • Imprisonment of up to 6 months for individuals, a fine, or both, according to MHRA guidance on GOV.UK
  • Personal criminal records for directors and responsible officers

Prosecution is not reserved for cases involving patient harm. The MHRA has powers to pursue enforcement action for regulatory non-compliance alone.

3. Civil Liability and Litigation Exposure

Selling a non-registered device in the UK opens up significant civil liability. If a device causes injury, or is alleged to have done so, the absence of proper MHRA registration can be raised against you in litigation.

Your insurance coverage may be at risk if you were operating outside the regulatory framework.

4. MHRA Audit and Inspection Action

The MHRA can inspect and audit manufacturers, distributors, and importers. If an inspection is triggered by a competitor complaint or a vigilance report, and you are found to be selling without registration, you can face enforcement action.

The MHRA assesses allegations of non-compliance and investigates adverse incident reports and intelligence about devices on the market.

5. Reputational Damage in a Close-Knit Market

The UK medical device market is large by revenue but tight by relationships. NHS procurement teams, distributors, and hospital groups share information about suppliers. An MHRA enforcement action against your brand, even one that gets resolved, tends to follow you.

A compliance failure in the UK could affect your ability to win NHS tenders and public sector contracts.

Who Is Most at Risk?

Who Is Most at Risk

From working with manufacturers entering the UK market, the companies most exposed to MHRA enforcement risk tend to share a few common characteristics:

  • EU-based manufacturers who achieved CE marking and assumed it covered the UK market post-Brexit
  • US and Asian manufacturers who appointed an EU Authorised Representative but have no UK Responsible Person in place
  • Startups that moved quickly into the UK market without completing the full regulatory checklist
  • Established companies that registered pre-Brexit and have not kept registrations current under the post-Brexit MHRA requirements
  • Distributors and importers who assumed the manufacturer had handled UK registration

If your company fits any of these descriptions, the priority is to find out exactly where you stand and address any gaps before they become an enforcement issue.

The Registration Gap Is Fixable, But Act Early

For lower-risk device classes, MHRA registration can often be completed relatively quickly when handled by people who know the process. The requirements are clear, and the MHRA’s goal is to have compliant devices on the market, not to exclude manufacturers who are making a genuine effort. That said, timelines vary significantly by device class. Class I devices typically move through the process faster than Class IIb or Class III products, so get specific guidance for your product category.

What matters is when you act. Manufacturers who identify and close a compliance gap themselves are in a much stronger position than those found to be non-compliant through enforcement action, which can bring the full range of consequences described above.

If you have any doubt about your MHRA registration status, now is the right time to check. Acting early puts you in a much stronger position than waiting until the issue is raised by someone else.

How Euverify Can Help

Euverify works with medical device manufacturers to navigate UK and EU regulatory requirements, covering MHRA registration, UK Responsible Person appointments, and ongoing post-market compliance obligations.

We support manufacturers based in the EU, US, and Asia-Pacific who need a trusted UK Responsible Person and a compliance partner with practical knowledge of what the MHRA actually requires.

We support Class I devices in full. Class IIa and IIb devices are supported where a Notified Body certificate and CE mark are in place and the documentation is complete, and Class III devices are accepted case by case.

We handle the registration process and stay involved to make sure you remain compliant as requirements evolve.

To learn more about our support for medical and IVD devices: https://euverify.com/medical-ivd-devices/

Frequently Asked Questions

Yes. EU MDR certification covers the EU single market. CE-marked MDR devices are recognised in Great Britain only until 30 June 2030, and that recognition does not replace MHRA registration. You need to register separately with the MHRA and appoint a UK Responsible Person regardless of your EU certification status.

Both roles give regulators a legally accountable contact on behalf of a foreign manufacturer, but they operate under entirely separate systems. An EU Authorised Representative covers you under EU MDR; a UK Responsible Person covers you under UK law for the GB market. If you sell into both territories, you need both.

All devices sold in Great Britain must be registered with the MHRA, but the wider requirements vary by classification. Class I devices have lighter-touch obligations than Class IIa, IIb, or Class III products, and IVDs and SaMD follow their own pathways. Always confirm your specific requirements with a regulatory professional, as UK and EU classifications do not always map directly.

For Northern Ireland only, yes. Under the Windsor Framework, CE-marked devices compliant with EU MDR can generally be sold there without MHRA registration. Since 28 May 2026, however, these devices must be registered on EUDAMED before being placed on the Northern Ireland market, and custom-made devices still register with the MHRA. If you are selling into England, Scotland, or Wales as well, MHRA registration for those territories is still required.

There is no renewal of the registration itself, but from 1 April 2026 an annual fee applies, and the account is suspended if it is not paid. Registration must also be kept current. You are required to notify the MHRA of any changes to your registration details. Post-market surveillance and vigilance reporting obligations also run on an ongoing basis.